On the whole, the present results indicate that PGC-1α overexpression is not sufficient to rescue muscle regeneration delay, although ameliorating the mitochondrial status, opening new possibilities to therapeutically modulate the metabolism in association with myogenesis-specific enhancers to impact on muscle regeneration in cancer cachexia. Here, PPARGC1A is linked to cancer.